NEW YORK (GenomeWeb News) – Compugen today posted a $2.4 million profit for the second quarter due entirely to the sale of $3.6 million worth of shares that it held in Evogene.

The Tel Aviv, Israel-based firm reported total revenues of $225,000 for the three-month period ended June 30, compared to revenues of $40,000 for the second quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Penn State researchers home in on a gene linked to the melting point of chocolate.

Researchers plan to share Ebola and MERS viral sequence data more quickly.

In PNAS this week: microbial communities of household dust, sequencing study of desiccation tolerance in the Resurrection Plant, and more.

Stanford University's Karl Deisseroth and Xiaoliang Sunney Xie from Harvard University are this year's recipients of the Albany Medical Center Prize.